BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26107232)

  • 1. Mutation Screening and Association Study of the Folylpolyglutamate Synthetase (FPGS) Gene with Susceptibility to Childhood Acute Lymphoblastic Leukemia.
    Piwkham D; Siriboonpiputtana T; Beuten J; Pakakasama S; Gelfond JA; Paisooksantivatana K; Tomlinson GE; Rerkamnuaychoke B
    Asian Pac J Cancer Prev; 2015; 16(11):4727-32. PubMed ID: 26107232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
    Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
    Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
    Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance.
    Wojtuszkiewicz A; Raz S; Stark M; Assaraf YG; Jansen G; Peters GJ; Sonneveld E; Kaspers GJ; Cloos J
    Int J Cancer; 2016 Apr; 138(7):1645-56. PubMed ID: 26547381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
    Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
    Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.
    Stark M; Wichman C; Avivi I; Assaraf YG
    Blood; 2009 Apr; 113(18):4362-9. PubMed ID: 19131550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the Polymorphism of Folylpolyglutamate Synthetase on Treatment of High-Dose Methotrexate in Pediatric Patients with Acute Lymphocytic Leukemia.
    Huang Z; Tong HF; Li Y; Qian JC; Wang JX; Wang Z; Ruan JC
    Med Sci Monit; 2016 Dec; 22():4967-4973. PubMed ID: 27987364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients.
    Lenz HJ; Danenberg K; Schnieders B; Goeker E; Peters GJ; Garrow T; Shane B; Bertino JR; Danenberg PV
    Oncol Res; 1994; 6(7):329-35. PubMed ID: 7865908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia.
    Raz S; Stark M; Assaraf YG
    Oncotarget; 2014 Oct; 5(19):9183-98. PubMed ID: 25229333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Association between the MiR146a Polymorphism and Susceptibility to Thai Childhood Acute Lymphoblastic Leukemia.
    Chansing K; Pakakasama S; Hongeng S; Thongmee A; Pongstaporn W
    Asian Pac J Cancer Prev; 2016; 17(5):2435-8. PubMed ID: 27268610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
    Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
    Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
    van der Straaten RJ; Wessels JA; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Allaart CF; Bogaartz J; Tiller M; Huizinga TW; Guchelaar HJ
    Pharmacogenomics; 2007 Feb; 8(2):141-50. PubMed ID: 17286537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
    Rots MG; Pieters R; Peters GJ; Noordhuis P; van Zantwijk CH; Kaspers GJ; Hählen K; Creutzig U; Veerman AJ; Jansen G
    Blood; 1999 Mar; 93(5):1677-83. PubMed ID: 10029597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel missense mutation of folypolyglutamate synthetase gene].
    Hu CY; Yue LJ; Yu J; Zhang HH; Yang CL
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):529-32. PubMed ID: 22809608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis of FPGS rs10760502G>a polymorphism with prognosis and MTX-related toxicity in pediatric B-cell acute lymphoblastic leukemia].
    Liu SG; Gao C; Li ZG; Li WJ; Cui L; Zhao XX; Zheng HY; Wu MY; Zhang RD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):291-7. PubMed ID: 24762994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription.
    Roy K; Mitsugi K; Sirlin S; Shane B; Sirotnak FM
    J Biol Chem; 1995 Nov; 270(45):26918-22. PubMed ID: 7592937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients.
    Muralidharan N; Sundaram R; Kodidela S; Chengappa KG; Mariaselvam CM; Misra DP; Negi VS
    Pharmacogenomics J; 2020 Apr; 20(2):342-349. PubMed ID: 31611592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in folylpolyglutamate synthase and gamma-glutamyl hydrolase and plasma homocysteine levels in the Singapore Chinese Health Study.
    Oppeneer SJ; Ross JA; Koh WP; Yuan JM; Robien K
    Mol Genet Metab; 2012 Jan; 105(1):73-8. PubMed ID: 22018726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.
    Tulstrup M; Moriyama T; Jiang C; Grosjean M; Nersting J; Abrahamsson J; Grell K; Hjalgrim LL; Jónsson ÓG; Kanerva J; Lund B; Nielsen SN; Nielsen RL; Overgaard U; Quist-Paulsen P; Pruunsild K; Vaitkeviciene G; Wolthers BO; Zhang H; Gupta R; Yang JJ; Schmiegelow K
    Blood; 2020 Sep; 136(10):1161-1168. PubMed ID: 32391884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia Patients.
    Muller IB; Lin M; Struys EA; Heydari P; Hebing RCF; Nurmohamed MT; van der Laken C; Lems WF; Cloos J; Jansen G; de Jonge R
    Ther Drug Monit; 2019 Oct; 41(5):598-606. PubMed ID: 31008996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.